Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price was down 31.3% on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32. The stock’s 50 day moving average price is C$0.10 and its two-hundred day moving average price is C$0.07.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Invest in the Best Canadian StocksÂ
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Steel Stocks Soaring After Tariff Announcements
- What is a Death Cross in Stocks?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
